Direct evidence in man for haploinsufficiency as the mechanism of action of myosin-binding protein C mutations that cause hypertrophic cardiomyopathy

Direct evidence in man for haploinsufficiency as the mechanism of action of myosin-binding protein C mutations that cause hypertrophic cardiomyopathy

Bibliographic Details
Main Authors:	Carballo, S, Copeland, O, Livesey, K, Jacques, A, McKenna, W, Redwood, C, Marston, S, Watkins, H
Format:	Conference item
Published:	2008

Similar Items

Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency.
by: Marston, S, et al.
Published: (2009)

Evidence for haploinsufficiency as the mechanism of action of MyBP-C mutations that cause HCM
by: Carballo, S, et al.
Published: (2008)

Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin
by: Toepfer, C, et al.
Published: (2019)

Identification of novel interactions between domains of Myosin binding protein-C that are modulated by hypertrophic cardiomyopathy missense mutations.
by: Moolman-Smook, J, et al.
Published: (2002)

Functional analysis of hypertrophic cardiomyopathy missense mutations in the light meromyosin region of beta myosin heavy chain
by: Redwood, C, et al.
Published: (2003)

Mutations of the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy.
by: Blair, E, et al.
Published: (2002)

Investigation of troponin I mutations causing familial hypertrophic cardiomyopathy
by: Abdulrazzak, H, et al.
Published: (2001)

OBSCN Mutations Associated with Dilated Cardiomyopathy and Haploinsufficiency.
by: Steven Marston, et al.
Published: (2015-01-01)

Haploinsufficiency of syncoilin leads to hypertrophic cardiomyopathy
by: Liang-Liang Fan, et al.
Published: (2022-11-01)

Comparison of the functional effects of mutations in troponin T which cause dilated and hypertrophic cardiomyopathies
by: Robinson, P, et al.
Published: (2002)

Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers
by: Javier Diez, et al.
Published: (2020-06-01)

The genetics of hypertrophic cardiomyopathy: Teare redux.
by: Watkins, H, et al.
Published: (2008)

Crystal structure of the C1 domain of cardiac myosin binding protein-C: implications for hypertrophic cardiomyopathy.
by: Govada, L, et al.
Published: (2008)

The prognostic impact of septal myectomy in obstructive hypertrophic cardiomyopathy.
by: Watkins, H, et al.
Published: (2005)

Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy
by: Maneiro Emilia, et al.
Published: (2010-04-01)

How do MYBPC3 mutations cause hypertrophic cardiomyopathy?
by: Marston, S, et al.
Published: (2012)

Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy.
by: Ashrafian, H, et al.
Published: (2011)

Normal passive viscoelasticity but abnormal myofibrillar force generation in human hypertrophic cardiomyopathy.
by: Hoskins, A, et al.
Published: (2010)

Myofibrillar Ca(2+) sensitivity is uncoupled from troponin I phosphorylation in hypertrophic obstructive cardiomyopathy due to abnormal troponin T.
by: Bayliss, C, et al.
Published: (2013)

Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C
by: Joshua A. Stern, et al.
Published: (2023-06-01)

PREVALENCE AND CLINICAL PROFILE OF CARDIAC MYOSIN-BINDING PROTEIN C GENE MUTATIONS ASSOCIATED WITH HYPERTROPHIC CARDIOMYOPATHY IN TUSCANY.
by: F. Girolami, et al.
Published: (2003-06-01)

Localization of the binding site of the C-terminal domain of cardiac myosin-binding protein-C on the myosin rod.
by: Flashman, E, et al.
Published: (2007)

Early onset malignant hypertrophic cardiomyopathy caused by mutations in MYBPC3
by: Carballo, S, et al.
Published: (2003)

Hypertrophic cardiomyopathy mutations in the pliant and light chain-binding regions of the lever arm of human β-cardiac myosin have divergent effects on myosin function
by: Makenna M Morck, et al.
Published: (2022-06-01)

Two mutations in troponin I that cause hypertrophic cardiomyopathy have contrasting effects on cardiac muscle contractility.
by: Burton, D, et al.
Published: (2002)

Novel mutations in cardiac MYBPC3 and early onset malignant hypertrophic cardiomyopathy
by: Carballo, S, et al.
Published: (2005)

Effects of hypertrophic cardiomyopathy mutations in troponin I on contractility of skinned cardiac muscle fibres
by: Burton, D, et al.
Published: (2002)

MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations
by: Li-rong Lin, et al.
Published: (2022-06-01)

Novel mutations in cardiac MYBPC3 causing early onset malignant hypertrophic cardiomyopathy
by: Carballo, S, et al.
Published: (2005)

Myosin-binding Protein C Compound Heterozygous Variant Effect on the Phenotypic Expression of Hypertrophic Cardiomyopathy
by: Julianny Freitas Rafael, et al.

Altered inhibitory and troponin C-binding activities in cardiac troponin I mutants known to cause hypertrophic cardiomyopathy
by: Elliott, K, et al.
Published: (2000)

Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
by: Blair, E, et al.
Published: (2003)

Structure-function relationships of eight mutations in troponin and tropomyosin that cause dilated cardiomyopathy
by: Mirza, M, et al.
Published: (2004)

β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity
by: Arjun S. Adhikari, et al.
Published: (2019-06-01)

Myosins and MyomiR Network in Patients with Obstructive Hypertrophic Cardiomyopathy
by: Chiara Foglieni, et al.
Published: (2022-09-01)

Novel mutations in cardiac MYPBC3 cause early onset malignant hypertrophic cardiomyopathy (HCM)
by: Carballo, S, et al.
Published: (2005)

Myosin sequestration regulates sarcomere function, cardiomyocyte energetics, and metabolism, informing the pathogenesis of hypertrophic cardiomyopathy
by: Toepfer, CN, et al.
Published: (2020)

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.
by: Ashrafian, H, et al.
Published: (2003)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
by: Hudsmith, L, et al.
Published: (2006)

Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype.
by: Mirza, M, et al.
Published: (2005)